Results
Between 2009 and 2019, we identified a total of 91 patients with
advanced cutaneous carcinoma, 11 patients with basal cell carcinomas
were excluded, 3 were lost to follow-up and 3 others refused surgical
treatment. The final group of 74 patients, all with laCSCC or reCSCC in
the head and neck region, was designated as the study group and divided
according to parotid metastases status into positive parotid metastasis
group (PM) with 37 patients who was compared to the without parotid
metastases (WPM) group with 37 patients.